
Natco Pharma Limited has informed the Exchange regarding a press release dated July 24, 2025, titled "NATCO Pharma Limited, API unit in Mekaguda Receives Establishment Inspection Report (EIR) from U.S. FDA".
Filed with NSE ·

Natco Pharma Limited has informed the Exchange regarding a press release dated July 24, 2025, titled "NATCO Pharma Limited, API unit in Mekaguda Receives Establishment Inspection Report (EIR) from U.S. FDA".
6ix hasn’t read this filing yet.
Follow NATCO Pharma into a list and get an email when it puts out news.
Follow NATCO Pharma